The Cystic Fibrosis Foundation said Wednesday that it would receive  billion for the sale of royalty rights to drugs developed with its financial support The payment is for the patient groups share of revenue from cysticfibrosis drugs like Kalydeco which Vertex Pharmaceuticals Inc developed with foundation funding The foundation has committed  million to fund Vertexs development of cystic fibrosis drugs and has already paid the company more than  million a Vertex spokesman said Foundation Chief Executive
  